Your browser is no longer supported. Please, upgrade your browser.
Hologic, Inc.
IndexS&P 500 P/E9.19 EPS (ttm)7.80 Insider Own0.10% Shs Outstand256.23M Perf Week-1.74%
Market Cap18.17B Forward P/E19.42 EPS next Y3.69 Insider Trans-12.34% Shs Float249.21M Perf Month-1.66%
Income2.04B PEG2.24 EPS next Q1.01 Inst Own97.10% Short Float1.58% Perf Quarter-2.93%
Sales5.66B P/S3.21 EPS this Y671.70% Inst Trans0.54% Short Ratio2.64 Perf Half Y8.20%
Book/sh15.13 P/B4.74 EPS next Y-52.61% ROA26.00% Target Price85.83 Perf Year1.04%
Cash/sh3.26 P/C21.96 EPS next 5Y4.10% ROE59.70% 52W Range60.10 - 85.00 Perf YTD-1.61%
Dividend- P/FCF8.08 EPS past 5Y56.10% ROI21.10% 52W High-15.69% Beta1.14
Dividend %- Quick Ratio1.30 Sales past 5Y6.90% Gross Margin68.90% 52W Low19.23% ATR1.39
Employees5814 Current Ratio1.70 Sales Q/Q42.00% Oper. Margin46.80% RSI (14)43.72 Volatility1.45% 1.89%
OptionableYes Debt/Eq0.81 EPS Q/Q96.50% Profit Margin36.00% Rel Volume0.62 Prev Close72.43
ShortableYes LT Debt/Eq0.69 EarningsNov 01 AMC Payout0.00% Avg Volume1.49M Price71.66
Recom1.60 SMA200.09% SMA50-4.90% SMA200-0.90% Volume920,657 Change-1.06%
Oct-15-21Resumed Cowen Outperform $83
Oct-14-21Initiated Redburn Neutral
Jul-06-21Upgrade Evercore ISI In-line → Outperform $78
Nov-20-20Downgrade Needham Buy → Hold
Nov-05-20Reiterated Needham Buy $78 → $88
Jun-30-20Upgrade Cowen Market Perform → Outperform $64
Jun-03-20Upgrade Raymond James Mkt Perform → Outperform $62
Apr-30-20Upgrade SVB Leerink Mkt Perform → Outperform $62
Apr-30-20Reiterated Needham Buy $52 → $60
Apr-07-20Upgrade Wells Fargo Equal Weight → Overweight $48
Mar-27-20Upgrade Morgan Stanley Underweight → Equal-Weight $40
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $24
Jan-13-20Reiterated Needham Buy $57 → $62
Jan-08-20Initiated Wells Fargo Equal Weight $57
Jan-07-20Initiated Citigroup Buy $60
Jan-02-20Downgrade Evercore ISI Outperform → In-line
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $54 → $59
Aug-01-19Reiterated Needham Buy $52 → $57
May-02-19Reiterated Needham Buy $50 → $52
Jan-31-19Reiterated Needham Buy $48 → $50
Oct-27-21 04:02PM  
Oct-26-21 09:38AM  
Oct-25-21 05:45PM  
Oct-22-21 11:22AM  
Oct-20-21 08:15AM  
Oct-19-21 08:00AM  
Oct-18-21 05:45PM  
Oct-14-21 04:02PM  
Oct-12-21 10:00AM  
Oct-11-21 05:45PM  
Oct-07-21 04:05PM  
Oct-05-21 05:45PM  
Oct-04-21 06:00AM  
Oct-01-21 10:15AM  
Sep-30-21 08:00AM  
Sep-28-21 05:45PM  
Sep-23-21 11:12AM  
Sep-22-21 09:50AM  
Sep-21-21 05:45PM  
Sep-15-21 05:45PM  
Sep-09-21 05:45PM  
Sep-02-21 04:04PM  
Aug-27-21 11:31AM  
Aug-24-21 11:06AM  
Aug-23-21 08:05AM  
Aug-13-21 03:08AM  
Jul-29-21 08:28AM  
Jul-28-21 10:32PM  
Jul-27-21 10:53AM  
Jul-26-21 08:02AM  
Jul-22-21 07:54AM  
Jul-21-21 03:02PM  
Jul-19-21 05:45PM  
Jul-15-21 08:06AM  
Jul-14-21 03:18AM  
Jul-13-21 05:45PM  
Jul-07-21 05:45PM  
Jul-06-21 09:43AM  
Jul-01-21 05:45PM  
Jun-29-21 08:30AM  
Jun-24-21 06:53AM  
Jun-23-21 05:45PM  
Jun-22-21 09:54AM  
Jun-17-21 05:45PM  
Jun-16-21 11:51AM  
Jun-14-21 03:34AM  
Jun-11-21 05:45PM  
Jun-10-21 10:25AM  
Jun-09-21 06:22AM  
Jun-03-21 04:27PM  
May-28-21 11:31AM  
May-27-21 09:00AM  
May-24-21 08:24AM  
May-15-21 05:52AM  
May-11-21 04:38PM  
May-10-21 05:44PM  
May-08-21 06:45AM  
May-07-21 10:21AM  
May-04-21 07:09PM  
Apr-29-21 09:46AM  
Apr-28-21 09:01PM  
Apr-27-21 08:56AM  
Apr-26-21 10:17AM  
Apr-23-21 11:40AM  
Apr-20-21 08:30AM  
Apr-19-21 05:45PM  
Apr-15-21 08:30AM  
Apr-12-21 06:10PM  
Apr-09-21 10:31AM  
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 10Option Exercise37.645,000188,20021,896Aug 12 04:14 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 10Sale77.485,000387,42516,896Aug 12 04:14 PM
Griffin John M.General CounselAug 09Option Exercise37.6426,6831,004,348150,283Aug 11 04:08 PM
Griffin John M.General CounselAug 09Sale75.6226,6832,017,768123,600Aug 11 04:08 PM
Daugherty Sean S.Group President, BSH & Surg.May 10Sale65.024,001260,14926,613May 12 04:08 PM
Bebo Allison PSVP, Human ResourcesFeb 05Sale84.066,100512,77835,680Feb 09 04:18 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerFeb 04Option Exercise39.968,396335,50425,048Feb 08 04:56 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerFeb 04Sale84.318,396707,86716,652Feb 08 04:56 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Option Exercise38.6916,869652,65842,452Dec 14 04:44 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerDec 10Sale73.641,477108,75916,575Dec 14 04:41 PM
Thornal Kevin RDiv. President, DiagnosticsDec 10Sale73.9916,8691,248,21233,216Dec 14 04:44 PM
Griffin John M.General CounselNov 18Option Exercise39.9622,900915,084157,386Nov 20 04:12 PM
Griffin John M.General CounselNov 18Sale71.0822,9001,627,689134,486Nov 20 04:12 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Option Exercise26.215,000131,05023,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 17Sale72.585,000362,90018,292Nov 19 04:10 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Option Exercise26.216,542171,46625,127Nov 16 04:24 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 12Sale70.606,542461,84618,585Nov 16 04:24 PM
GARRETT SCOTT TDirectorNov 09Option Exercise22.3511,146249,11362,531Nov 12 04:26 PM
Stamoulis ChristianaDirectorNov 04Option Exercise22.3511,146249,11350,538Nov 06 04:10 PM
Stamoulis ChristianaDirectorNov 04Sale74.0011,146824,80439,392Nov 06 04:10 PM